These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 1997173)

  • 1. Further studies of the action of a partially purified bacteriocin against a murine fibrosarcoma.
    Hill RP; Farkas-Himsley H
    Cancer Res; 1991 Mar; 51(5):1359-65. PubMed ID: 1997173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-tumor activity of recombinant tumor necrosis factor on mouse fibrosarcoma in vivo and in vitro.
    Tomazic VJ; Farha M; Loftus A; Elias EG
    J Immunol; 1988 Jun; 140(11):4056-61. PubMed ID: 3372997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection by S-2-(3-aminopropylamino)ethylphosphorothioic acid against radiation- and cyclophosphamide-induced attenuation in antitumor resistance.
    Milas L; McBride WH; Hunter N; Ito H
    Cancer Res; 1984 Jun; 44(6):2382-6. PubMed ID: 6327014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response of the FSaII fibrosarcoma to antiangiogenic modulators plus cytotoxic agents.
    Teicher BA; Holden SA; Ara G; Northey D
    Anticancer Res; 1993; 13(6A):2101-6. PubMed ID: 7507654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leech salivary gland extract from Haementeria officinalis, a potent inhibitor of cyclophosphamide- and radiation-induced artificial metastasis enhancement.
    Gasic GJ; Iwakawa A; Gasic TB; Viner ED; Milas L
    Cancer Res; 1984 Dec; 44(12 Pt 1):5670-6. PubMed ID: 6498828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
    Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of continuous administration of interleukin 2 on active specific chemoimmunotherapy with extracted tumor-specific transplantation antigen and cyclophosphamide.
    Naito K; Pellis NR; Kahan BD
    Cancer Res; 1988 Jan; 48(1):101-8. PubMed ID: 3257158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting toll-like receptor 9 with CpG oligodeoxynucleotides enhances tumor response to fractionated radiotherapy.
    Mason KA; Ariga H; Neal R; Valdecanas D; Hunter N; Krieg AM; Whisnant JK; Milas L
    Clin Cancer Res; 2005 Jan; 11(1):361-9. PubMed ID: 15671567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Classification of antineoplastic treatments by their differential toxicity toward putative oxygenated and hypoxic tumor subpopulations in vivo in the FSaIIC murine fibrosarcoma.
    Teicher BA; Holden SA; al-Achi A; Herman TS
    Cancer Res; 1990 Jun; 50(11):3339-44. PubMed ID: 2334928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ineffectiveness of adoptive chemoimmunotherapy with lymphokine-activated killer cells, interleukin-2, and cyclophosphamide on palpable intradermal murine bladder cancer.
    Lee K; O'Donnell RW; Cockett AT
    J Biol Response Mod; 1988 Feb; 7(1):43-53. PubMed ID: 3259620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of mitomycin C for aerobic and hypoxic cells in vitro and in vivo.
    Rauth AM; Mohindra JK; Tannock IF
    Cancer Res; 1983 Sep; 43(9):4154-8. PubMed ID: 6409398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling growth kinetics and statistical distribution of oligometastases.
    Withers HR; Lee SP
    Semin Radiat Oncol; 2006 Apr; 16(2):111-9. PubMed ID: 16564446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapy of artificial and spontaneous metastases of murine tumors with maleic anhydride-divinyl ether-2.
    Milas L; Hersh EM; Hunter N
    Cancer Res; 1981 Jun; 41(6):2378-85. PubMed ID: 7237436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant human tumor necrosis factor-alpha: evidence of an indirect mode of antitumor activity.
    Manda T; Shimomura K; Mukumoto S; Kobayashi K; Mizota T; Hirai O; Matsumoto S; Oku T; Nishigaki F; Mori J
    Cancer Res; 1987 Jul; 47(14):3707-11. PubMed ID: 3594435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of tumor size on S-2-(3-aminopropylamino)ethylphosphorothioic acid and misonidazole alteration of tumor response to cyclophosphamide.
    Milas L; Ito H; Hunter N
    Cancer Res; 1983 Jul; 43(7):3050-6. PubMed ID: 6303574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxicity of diethylaminoreserpine to a transplantable tumor: the significance of the presence of hypoxic cells.
    Lehnert S
    Cancer Res; 1982 Aug; 42(8):3028-32. PubMed ID: 7093951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the vascular disrupting agent ZD6126 on interstitial fluid pressure and cell survival in tumors.
    Skliarenko JV; Lunt SJ; Gordon ML; Vitkin A; Milosevic M; Hill RP
    Cancer Res; 2006 Feb; 66(4):2074-80. PubMed ID: 16489007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of novobiocin on the antitumor activity and tumor cell and bone marrow survivals of three alkylating agents.
    Eder JP; Teicher BA; Holden SA; Cathcart KN; Schnipper LE; Frei E
    Cancer Res; 1989 Feb; 49(3):595-8. PubMed ID: 2910481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partially purified bacteriocin kills malignant cells by apoptosis: programmed cell death.
    Farkas-Himsley H; Zhang YS; Yuan M; Musclow CE
    Cell Mol Biol (Noisy-le-grand); 1992; 38(5-6):643-51. PubMed ID: 1483114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor activity of lentinan in murine syngeneic and autochthonous hosts and its suppressive effect on 3-methylcholanthrene-induced carcinogenesis.
    Suga T; Shiio T; Maeda YY; Chihara G
    Cancer Res; 1984 Nov; 44(11):5132-7. PubMed ID: 6488173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.